Lumida
/WVE
⌘K
WAVE Life Sciences Ltd

WAVE Life Sciences Ltd

WVE
$5.82USD+2.65%+0.15 today

MARKET CAP

1.1B

P/E (TTM)

FWD P/E

DAY RANGE

$6 – $6

52W RANGE

$5
$22

AI Summary

Stalk
Buy NowMedium

The stock is building an early Stage 1 base after the panic-driven flush, with price tightly tracking above the rising 9 and 21 EMAs and showing stabilization. The Post-Capitulation pattern confirms exhaustion of selling pressure, supporting a medium-term bullish bias ahead of a potential Stage 2 transition. Short-term execution is favorable as momentum remains positive and no overbought signals are evident. Participation now at EMA support aligns with the momentum-oriented strategy seeking continuation.

  • Q1 2026 revenue rose 315% YoY to $38.2 M, driven by WVE-006/007.
  • Phase 1 WVE-007 cut visceral fat 14.3% and total fat 5.3%.
  • Q1 net loss of $26.1 M reflects ongoing unprofitability.
Full analysis →
Insider Trades23 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 26, 2026SellWVEChris Francis66,388$9.66$1.1B-73.22%+15.94%$641.5K+0.00%10b5-1Buy Now
Feb 9, 2026SellWVEChris Francis1,883$13.45$1.1B-73.22%+15.94%$25.3K-0.64%Buy Now
Feb 9, 2026SellWVEChandra Vargeese3,228$13.45$1.1B-73.22%+15.94%$43.4K-0.47%Buy Now
Feb 9, 2026SellWVEKyle MoranChief Financial Officer3,588$13.45$1.1B-73.22%+15.94%$48.3K-0.87%Buy Now
Feb 9, 2026SellWVEPaul BolnoPresident and CEO10,480$13.45$1.1B-73.22%+15.94%$141.0K-0.81%Buy Now
Jan 2, 2026SellWVEChris Francis18,750$9.58$1.1B-73.22%+15.94%$179.7K+0.00%10b5-1Buy Now
Dec 8, 2025BuyWVEKyle MoranChief Financial Officer556,036$10.15$1.1B-73.22%+15.94%$5.6M+2.26%10b5-1Buy Now
Dec 8, 2025SellWVEChris Francis882,062$9.68$1.1B-73.22%+15.94%$8.5M+0.00%10b5-1Buy Now
Aug 22, 2025SellWVEPaul BolnoPresident and CEO217,351$10.10$1.1B-73.22%+15.94%$2.2M-64.24%10b5-1Buy Now
Mar 7, 2025SellWVEPaul BolnoPresident and CEO338,050$6.03$1.1B-73.22%+15.94%$2.0M+0.00%10b5-1Buy Now
Mar 4, 2025BuyWVEChandra Vargeese91,754$2.48$1.1B-73.22%+15.94%$227.5K+33.87%Buy Now
Jan 23, 2025BuyWVEChandra Vargeese46,000$2.48$1.1B-73.22%+15.94%$114.1K+22.51%Buy Now
Nov 25, 2024SellWVEPaul BolnoPresident and CEO100,000$8.74$1.1B-73.22%+15.94%$874.0K+0.00%10b5-1Buy Now
Nov 15, 2024SellWVEPaul BolnoPresident and CEO51,234$14.32$1.1B-73.22%+15.94%$733.7K-19.08%10b5-1Buy Now
Nov 8, 2024SellWVEChris Francis72,000$12.09$1.1B-73.22%+15.94%$870.1K+0.00%10b5-1Buy Now
Oct 16, 2024SellWVEPaul BolnoPresident and CEO90,474$15.00$1.1B-73.22%+15.94%$1.4M-25.20%10b5-1Buy Now
Oct 16, 2024SellWVEChris Francis337,958$9.55$1.1B-73.22%+15.94%$3.2M-25.25%10b5-1Buy Now
Oct 11, 2024BuyWVEKyle MoranChief Financial Officer25,000$2.48$1.1B-73.22%+15.94%$62.0K+126.41%Buy Now
Sep 25, 2024SellWVEKyle MoranChief Financial Officer17,146$9.00$1.1B-73.22%+15.94%$154.3K-46.44%10b5-1Buy Now
Aug 21, 2024SellWVEPaul BolnoPresident and CEO48,366$5.78$1.1B-73.22%+15.94%$279.6K-11.87%10b5-1Buy Now
Jul 22, 2024BuyWVEChandra Vargeese68,210$2.48$1.1B-73.22%+15.94%$169.2K+35.49%Buy Now
Apr 3, 2024SellWVEKyle MoranChief Financial Officer15,630$6.17$1.1B-73.22%+15.94%$96.4K-31.54%10b5-1Buy Now
Aug 23, 2023SellWVEKyle MoranChief Financial Officer37,062$4.75$1.1B-73.22%+15.94%$176.1K-44.56%10b5-1Buy Now